Trial Profile

A Pharmacodynamic and Pharmacokinetic Study of CM4620 Injectable Emulsion (CM4620-IE) in Patients With Acute Pancreatitis

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 05 May 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Zegocractin (Primary)
Indications Pancreatitis
Focus Therapeutic Use
Sponsors CalciMedica

Most Recent Events

07 Nov 2019 Results published in the CalciMedicaMedia Release.
07 Nov 2019 According to an CalciMedica media release, Dr. Joseph Miller is the principal investigator for this study.
07 Nov 2019 According to an CalciMedica media release, this study will be presented as a poster at the American Pancreas Association annual meeting.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com